Mylan will now move forward with its plans to tender a formal offer directly to Perrigo’s shareholders.
Dr. Reddy’s Laboratories on Thursday announced several senior level changes in their global management structure.
Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths.
When asked about readiness in the face of a cyber-attack, 66% of executives at health plans said they were prepared, while only 53% of providers said they were ready.
See some of the biggest innovations in pharmacy technology from the 2015 National Association of Chain Drug Stores’ Total Store Expo.
Sermo, a social network for physicians, announced Wednesday that 69% of doctors think parents are either completely or mostly to blame for the childhood obesity epidemic.
Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.
Medication adherence solutions company e-pill announced Wednesday that it had started selling its MedTime Plus Medication Reminder and Dispensing system.
Although 94% of consumers say that some people are particularly vulnerable to getting the flu, about 41% typically do not get a flu shot, according to a new online survey of Kmart shoppers.